Greenwich LifeSciences, Inc. (GLSI) NASDAQ
24.29
-4.22(-14.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 284.37M |
| Enterprise Value | 291.11M |
| P/E Ratio | -17.12 |
| PEG Ratio | 0.99 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 151.65 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -17.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -5.08 |
| Return On Equity | -10.36 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1,779 |
| EBITDA | -19.45M |
| Net Income | -19.36M |
| Diluted EPS | -1.43 |
Balance Sheet
| Total Cash | 3.81M |
| Total Cash/Share | 0.28 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.35 |
| Book Value Per Share | 0.16 |
Price History
| 52-Week Change | 151.97 |
| 52-Week High | 34.1 |
| 52-Week Low | 7.78 |
| Moving Average 50 Days | 24.95 |
| Moving Average 200 Days | 18.46 |
Statistics
| Average Volume | 150,200 |
| Shares Outstanding | 13.85M |
| % Held by Institutions | 12.56 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
